Chicken collagen type II reduces articular cartilage destruction in a model of osteoarthritis in rats

West Indian Medical Journal

Volumn 56, Issue 3, 2007, Pages 202-207

  Xu, D ^a   Shen, W ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN K; COLLAGEN TYPE 2; COLLAGENASE 3; EOSIN; GELATINASE B; HEMATOXYLIN; MESSENGER RNA; PLACEBO; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTICULAR CARTILAGE; CARTILAGE DEGENERATION; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; KNEE OSTEOARTHRITIS; NONHUMAN; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCORING SYSTEM;

EID: 36749095728     PISSN: 00433144     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0043-31442007000300002     Document Type: Article

References (17)

1. Zhang LL, Wei W, Yan SX, Hu XY, Sun WY. Therapeutic effects of glucosides of Cheanomeles speciosa on collagen-induced arthritis in mice. Acta Pharmacol Sin 2004; 25: 1495-501.
2. Chen XH, Bai JY, Shen F, Bai AP, Guo ZR, Chen GF. Imrecoxib: a novel and selective cyclooxygenase 2 inhibitor with anti-inflammatory effect. Acta Pharmacol Sin 2004; 25: 927-31.
3. Tamura T, Shirai T, Kosaka N, Ohmori K, Takafumi N. Pharmacological studies of diacerein in animal models of inflammation, arthritis and bone resorption. Eur J Pharmacol 2002; 448: 81-7.
4. Meyer O. Oral immunomodulation therapy in rheumatoid arthritis. Joint Bone Spine 2000; 67: 384-92.
5. Garcia G, Komagata Y, Slavin AJ, Maron R, Weiner HL. Suppression of collagen-induced arthritis by oral or nasal administration of type II collagen. J Autoimmu 1999; 13: 315-24.
6. Hayami T, Funaki H, Yaoeda K, Mitui K, Yamagiwa H, Tokunaga K et al. Expression of the cartilage derived anti-angiogenic factor chondromodulin-I dreases in the early stage of experimental osteoarthritis. J Rheumalol 2003; 30: 2207-17.
7. Muller B. Cytokine imbalance in non-immunological chronic disease. Cytokine 2002; 18: 334-9.
8. Shi W, Wang YM, Li SL, Yan M Li D, Chen BY et al. Risk factors of adverse drug reaction from non-steroidal anti-inflammatory drugs in Shanghai patients with arthropathy. Acta Pharmacol Sin 2004; 25: 357-65.
9. Haynes MK, Hume EL, Smith JB. Phenotypic characterization of inflammatory cells from osteoarthritic synovium and synovial fluids. Clinical Immunology 2002; 105: 315-25.
10. Pelletier JP, Martel-Pelletier J, Abramson SB. Osteoarthritis, a inflammation disease: potential implications for the selection of new therapeutic targets. Arthritis Rheum 2001; 44: 1237-47.
11. Sylvester J, Liacini A, Li WQ, Zafarullah M. Interleukin-17 signal transduction pathways implicated in inducing matrix metalloproteinase-3, -13 and aggrecanase-1 genes in articular chondrocytes. Cell Signal 2004; 16: 469-76.
12. Hellio Le Graverand MP, Eggerer J Sciore P, Reno C, Vigmen E, Otterness I etal. Matrix metalloproteinase-13 expression in rabbit knee joint connective tissues: Influence of maturation and response to injury. Matrix Biology 2000; 19: 431-41
13. Dreier R, Grassel S, Fuchs S, Schaumburger J, Bruckner P. Pro-MMP-9 is a specific macrophage product and is activated by osteoarthritic chondrocytes via MMP-3 or a MTI-MMP/MMP-13 cascade. Experiment Cell Research 2004; 297: 303-12.
14. Konttinen YT, Mandelin J, Li TF, Salo J, Laussus J, Liliestrom M et al. Acidic cysteine endoproteinase cathepsin K in the degeneration of the superficial articular hyaline cartilage in ostcoarthritis. Arthritis Rheum 2002; 46: 953-60.
15. Hou WS, Li Z, Keyszer G, Weber E, Levy R, Klein MJ, Gravallese Em et al. Comoarison of cathepsin K and S expression with in the rheumatoid and osteoarthritic synovium. Arthritis Rheum 2002; 46: 663-74.
16. Liacini A, Sylvester J, Li WQ, Zafarullah M. Inhibition of interleukin-1-stimulated MAP kinases, activating protein-I (AP-1) and nuclear factor kappa B (NF-kB) transcription factors down-regulates matrix metalloproteinase gene expression in articular chondrocytes. Matrix Biol 2002; 21: 251-62.
17. Liacini A, Sylvester J, Li WQ, Huang W, Dchnade F, Ahmad et al. Induction of matrix metalloproteinase-13 gene expression by TNFa is mediated by MAP kinases, AP-1, and NF-kB transcription factors in articular chondrocytes. Exp Cell Res 2003; 288: 208-17.